
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated July 26, 2025, titled "Revised Press Release for Unaudited Financial results for the quarter ended June 30, 2025".
Filed with NSE ·

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated July 26, 2025, titled "Revised Press Release for Unaudited Financial results for the quarter ended June 30, 2025".
6ix hasn’t read this filing yet.
Jagsonpal Pharmaceuticals Ltd. on 6ix
Follow Jagsonpal Pharmaceuticals into a list and get an email when it puts out news.
Follow Jagsonpal Pharmaceuticals